西隴科學(002584.SZ):擬以5.04億元轉讓艾克韋生物60%股權
格隆匯12月7日丨西隴科學(002584.SZ)公佈,2021年12月7日,公司與甲方一濟南高新實業發展有限公司、甲方二濟南高新財金投資有限公司、甲方三濟南高新盛和發展有限公司簽訂了《股權轉讓協議》,將公司持有的艾克韋生物60%的股權以人民幣5.04億元的價格轉讓給甲方,其中向甲方一轉讓的股權比例為27.2202%,向甲方二轉讓的股權比例為16.5714%,向甲方三轉讓的股權比例為16.2084%,同時公司將持有的剩餘13.7801%股權表決權委託甲方一代為行使。此次交易不構成關聯交易,不會導致公司控制權的變更,也不構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
此次股權轉讓完成後,艾克韋生物及其子公司將不再納入公司合併報表範圍。公司對艾克韋生物剩餘的13.7801%股權不具有共同控制能力或重大影響,後續計入其他權益工具投資。
此次交易完成後,有利於增加公司現金流入,所得款項將用於公司生產經營及轉型升級發展,集中優勢發展主營業務。經公司初步測算,公司此次股權轉讓將產生投資收益的區間為4500萬元至6500萬元(未經審計),將計入此次股權轉讓完成當年度的合併報表當期損益,最終數據以公司當年經審計的財務報吿數據為準。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.